Copyright
©The Author(s) 2022.
World J Gastroenterol. Mar 28, 2022; 28(12): 1226-1238
Published online Mar 28, 2022. doi: 10.3748/wjg.v28.i12.1226
Published online Mar 28, 2022. doi: 10.3748/wjg.v28.i12.1226
Categories | Similarity | Difference | Interaction |
Epidemiology | High prevalence in developing countries[1] | HEV infects humans and animals[6,7] | Co-infections or superinfections[2,3] |
Genetic variability | RNA viruses (quasispecies), genotype classification, recombination events[4,5] | Replication rate, HEV has non-enveloped or quasi-enveloped virions[12,26] | None |
Pathogenesis | Disease progression in immunocompromised patients[32,54] | Microbiota alteration, hepatic severity[23,33,83,84] | HEV could influence hepatic or extrahepatic symptoms in patients with chronic HCV infection[2,3] |
Treatment | Choice of therapy[35,50] | PEG-IFN-α and RBV are still the therapies of choice for HEV[35] | DAA therapy can be effective against both viruses[50,53] |
Prevention | Public health measures[58] | Vaccine availability[60,62] | Improvement of screening policies[35,50] |
- Citation: Marascio N, Rotundo S, Quirino A, Matera G, Liberto MC, Costa C, Russo A, Trecarichi EM, Torti C. Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice . World J Gastroenterol 2022; 28(12): 1226-1238
- URL: https://www.wjgnet.com/1007-9327/full/v28/i12/1226.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i12.1226